Phase 1 study of anti-immunoglobulin-like transcript 3 (ILT3) monoclonal antibody (mAb) MK-0482+pembrolizumab (pembro) in patients with recurrent inoperable glioblastoma (GBM)

被引：0

作者：

Kim, Tae Min

Kim, Sang-We

Gutierrez, Martin

Di Giacomo, Anna Maria

Voskoboynik, Mark

Myer, Nicole

Edmondson, Mackenzie

Liu, Qi

Chen, Mei

Victoria, Ivan

机构：

[1] Seoul Natl Univ Hosp, Seoul, South Korea

[2] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea

[3] Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA

[4] Univ Siena, Siena, Italy

[5] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy

[6] Alfred Hlth, Alfred, NY, Australia

[7] Merck & Co Inc, Rahway, NJ USA

[8] Hosp Clin Barcelona, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2046

引用

页数：1